Bio-Techne Corp
TECH: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$54.00 | Jphfv | Zhfddrfmb |
Bio-Techne's Long-Term Goals on Track and Strategic Direction Likely Unaffected by CEO Transition
Business Strategy and Outlook
Bio-Techne is a market leader in proteins for the pharma, biotech, academic, and diagnostic markets and maintains strong market positioning in antibodies and testing controls for diagnostic partners.